Non-antibiotic medication linked to antibiotic resistance
Common non-antibiotic medications like anti-inflammatories and a lipid-lowering cholesterol drug can accelerate the spread of antibiotic resistance, according to new research from The University of Queensland (UQ).
As explained by UQ Associate Professor Jianhua Guo, non-antibiotic pharmaceuticals make up more than 95% of the drug market worldwide yet their effects on antibiotic resistance are largely unknown.
“When we think of antibiotic resistance, we often link it to the intensive use of antibiotics for medical, veterinary or agricultural purposes,” he said.
“We started wondering if non-antibiotic pharmaceuticals may also play a role in the spread of antibiotic resistance through bacterial transformation.
“Antibiotic resistance occurs and spreads when bacteria uptake free-living antibiotic resistance genes (ARGs) via bacterial transformation in response to the use of antibiotics.”
UQ researchers investigated if the same process linked to antibiotics also occurs with widely used non-antibiotic pharmaceuticals such as nonsteroidal anti-inflammatory drugs, which 30 million people worldwide consume daily. PhD student Yue Wang said the research team tested six commonly consumed non-antibiotic pharmaceuticals, with the results published in The ISME Journal.
“We did find nonsteroidal anti-inflammatories, a lipid-lowering drug and a β-blocker significantly promoted the bacterial transformation,” she said.
“Given the high consumption of non-antibiotic pharmaceuticals, our findings highlight a new concern that non-antibiotic pharmaceuticals can speed up the dissemination of antibiotic resistance.”
Assoc Prof Guo said the study broadens our view of antibiotic resistance and that further research is clearly needed.
“They are the iceberg of factors for promoting antibiotic resistance, and should not be ignored,” he said.
Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
Australia announces $7.2m diphtheria outbreak response package
To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...
MV Hondius passengers return to Australia under strict infection control measures
The Australian CDC has provided an update on hantavirus risk to Australians and infection...
